Patent assignee · DE · COMPANY

Biotest AG

44Patents
33Active
44Granted
49Portfolio score

Filing activity: Jan 4, 1989 → Dec 2, 2022 · 17 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7452981B2 Humanized anti-CD4 antibody with immunosuppressive properties Chemistry; Metallurgy 75 Expired
US6120989A Isolated human cytomegalovirus polypeptides and uses thereof Emerging Cross-Sectional Technologies 30 Expired
US7659247B2 Production of a von Willebrand factor preparation having a high specific activity Chemistry; Metallurgy 24 Active
US8673304B2 Humanized anti-CD4 antibody with immunosuppressive properties Chemistry; Metallurgy 19 Active
US8440806B2 Humanized anti-CD4 antibody with immunosuppressive properties Chemistry; Metallurgy 19 Active
US9758581B2 Humanized anti-CD4 antibody with immunosuppressive properties Chemistry; Metallurgy 18 Active
US9011864B2 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates Chemistry; Metallurgy 16 Active
US5523214A Method of visually demonstrating the presence of microorganisms, identifying them, and testing them for sensitivity to antibiotics with redox indicators Emerging Cross-Sectional Technologies 11 Expired
US10117932B2 Uses of immunoconjugates targeting CD138 Human Necessities 7 Active
US6168930A Change in system Chemistry; Metallurgy 7 Expired
US9289509B2 Uses of immunoconjugates targeting CD138 Performing Operations; Transporting 6 Active
US5213963A Procedure for finding and identifying red cell antibodies by means of the solid phase method Emerging Cross-Sectional Technologies 6 Expired
US6617126B1 Method for improving the growth and colorimetric detection of bacteria, yeasts, fungi or cocci Chemistry; Metallurgy 5 Expired
US9221914B2 Agents targeting CD138 and uses thereof Chemistry; Metallurgy 5 Active
US8956607B2 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Chemistry; Metallurgy 4 Active
US9387261B2 Immunoconjugates targeting CD138 and uses thereof Chemistry; Metallurgy 3 Active
US4925786A Method of determining blood groups by the solid-phase procedure with blood-group specific antibodies of the immunoglobulin M. type and support and kit for carrying out the method Physics 3 Expired
US8840898B2 Immunoconjugates targeting syndecan-1 expressing cells and use thereof Human Necessities 3 Active
US6177080A Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy Chemistry; Metallurgy 2 Expired
US8852871B2 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Chemistry; Metallurgy 2 Active
US7939643B2 Production of a von Willebrand factor preparation using hydroxylapatite Chemistry; Metallurgy 2 Active
US8586715B2 Humanized anti-CD4 antibody with immunosuppressive properties Chemistry; Metallurgy 1 Active
US6908745B2 Gamma sterilizable culture medium for the identification of yeasts and fungi Chemistry; Metallurgy 1 Expired
US9243056B2 Process for preparing an immunoglobulin composition Chemistry; Metallurgy 1 Active
US9334325B2 Method for treating psoriasis Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.